L-Thyroxine

CAT:
804-HY-18341-01
Size:
500 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
L-Thyroxine - image 1

L-Thyroxine

  • UNSPSC Description:

    L-Thyroxine (Levothyroxine; T4) is a synthetic hormone for the research of hypothyroidism. DIO enzymes convert biologically active thyroid hormone (Triiodothyronine,T3) from L-Thyroxine (T4)[1].
  • Target Antigen:

    Endogenous Metabolite; Thyroid Hormone Receptor
  • Type:

    Natural Products
  • Related Pathways:

    Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
  • Field of Research:

    Endocrinology; Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/l-thyroxine.html
  • Purity:

    99.49
  • Solubility:

    1M NaOH : 5 mg/mL (ultrasonic;warming;adjust pH to 11 with NaOH;heat to 60°C)|DMSO : 233.33 mg/mL (ultrasonic)|H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C)
  • Smiles:

    N[C@@H](CC1=CC(I)=C(C(I)=C1)OC2=CC(I)=C(O)C(I)=C2)C(O)=O
  • Molecular Weight:

    776.87
  • References & Citations:

    [1]Arici M, et al. Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients. Endocr J. 2018 Mar 28;65(3):317-323.|[2]Corriveau S, et al. Levothyroxine treatment generates an abnormal uterine contractility patterns in an in vitro animalmodel. J Clin Transl Endocrinol. 2015 Sep 9;2(4):144-149.Cell Rep Med. 2023 May 24;101061.|Dis Model Mech. 2024 Aug 14:dmm.050748.|EMBO J. 2024 Jun 5.|Mol Brain. 2021 Jan 27;14(1):25.|Nat Immunol. 2024 Mar 18.|Sci Rep. 2022 Jul 4;12(1):11259.|Stem Cell Rev Rep. 2021 Jun;17(3):999-1013.|J Drug Deliv Sci Technol. 2023 Sep 28, 105008.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Clinical Information:

    Launched
  • CAS Number:

    51-48-9